Tumor cells expressing PD-L1, or PD-L2, that can interact with PD-1 will suppress T cell receptor-mediated cytotoxicity and CD8+ T cell proliferation, thus avoiding the killing effect of the autoimmune system and escaping from immune surveillance [23, 24, 18]. Here, PDCD1 is linked to neoplasm.